MOTS is on an upward trend. This biotech company has only been trading for several months and has started to trend up after testing its support at $4.35. Analyst price targets for long term have MOTS going to as much as $12. If this can break through its high of $7.87 from 12 days ago we could see a blue sky break out. On the 5min chart it is showing a bull flag.